Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-08-002031
Filing Date
2008-02-29
Accepted
2008-02-29 14:34:35
Documents
9
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2182951z10-k.htm 10-K 861106
2 EXHIBIT 10.35 a2182951zex-10_35.htm EX-10.35 123586
3 EXHIBIT 21 a2182951zex-21.htm EX-21 5076
4 EXHIBIT 23.1 a2182951zex-23_1.htm EX-23.1 4495
5 EXHIBIT 31.1 a2182951zex-31_1.htm EX-31.1 6867
6 EXHIBIT 31.2 a2182951zex-31_2.htm EX-31.2 6889
7 EXHIBIT 32.1 a2182951zex-32_1.htm EX-32.1 3593
8 EXHIBIT 32.2 a2182951zex-32_2.htm EX-32.2 3628
9 G358049.JPG g358049.jpg GRAPHIC 23050
  Complete submission text file 0001047469-08-002031.txt   1048673
Mailing Address COVANCE INC 210 CARNEGIE CENTER PRINCETON NJ 08540
Business Address 210 CARNEGIE CENTER PRINCETON NJ 08540 6094524440
COVANCE INC (Filer) CIK: 0001023131 (see all company filings)

EIN.: 223265977 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12213 | Film No.: 08654711
SIC: 8731 Services-Commercial Physical & Biological Research